Clinical best practices in optimal monitoring, early diagnosis, and effective management of antibody–drug conjugate-induced interstitial lung disease or pneumonitis: a multidisciplinary team approach in Singapore

Autor: Yong, Wei Peng, Teo, Felicia SW, Teo, Lynette LS, Ng, Matthew CH, Tan, Tira J., Low, Su Ying, Wong, Karmen, Ang, Peter, Choo, Su Pin, Lee, Kim Hua, Lee, Soo Chin

Publikováno v: Expert Opinion on Drug Metabolism & Toxicology; December 2022, Vol. 18 Issue: 12 p805-815, 11p

Chemoradiation-induced changes in systemic inflammatory markers and their prognostic significance in oesophageal squamous cell carcinoma.

Autor: Khin, Ni Sann, Tan, Sze Huey, Wang, Michael LC, Siow, Tian Rui, Lim, Faye LWT, Wang, Fu Qiang, Ng, Matthew CH, Lam, Justina YC, Yip, Connie

Publikováno v: British Journal of Radiology; Jun2021, Vol. 94 Issue 1122, pN.PAG-N.PAG, 1p

Overcoming the impact of the COVID-19 pandemic on oncology early phase trials and drug development in Asia-Experiences and perspectives of the Asian Oncology Early Phase 1 Consortium.

Autor: Shimizu T; Early Phase 1 Drug Development Service, Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Kim DW; Department of Internal Medicine, Clinical Trials Center, Seoul National University Hospital, Seoul, South Korea., Loong HH; Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Lin CC; Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Ng MC; Experimental Cancer Therapeutics Unit, Division of Medical Oncology, National Cancer Centre Singapore, Singapore., Yamamoto N; Early Phase 1 Drug Development Service, Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Ma B; Phase 1 Clinical Trial Centre, The Chinese University of Hong Kong, Hong Kong SAR, China.; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China., Tan DS; Experimental Cancer Therapeutics Unit, Division of Medical Oncology, National Cancer Centre Singapore, Singapore.

Publikováno v: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Aug; Vol. 17 (4), pp. 388-395. Date of Electronic Publication: 2021 Jan 27.